BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 10, 2015
View Archived Issues
Preclinical and phase I efficacy of a first-in-class ADC against tumor-initiating cells
Read More
RedHill Biopharma reports additional data from phase III RHB-105 study
Read More
Domain Therapeutics identifies mGlu2/3 receptor modulators for PD non-motor symptoms
Read More
GeoVax's Ebola vaccine shows efficacy in rodent models
Read More
Pierre Fabre and Addex Therapeutics form CNS program agreement
Read More
Recent agreements to develop cancer drugs and diagnostics
Read More
Faron Pharmaceuticals announces share offer to fund phase III trial of Traumakine
Read More
Purdue Pharma acquires rights to TrkA program from VM Pharma
Read More
Canadian funding for VBI Vaccines' development of RSV vaccine
Read More
New antimalarial classes discovered at the Walter Reed Army Institute
Read More
FDA grants priority review to ixazomib for relapsed/refractory multiple myeloma
Read More
Santhera receives European approval for Raxone in Leber's hereditary optic neuropathy
Read More
University of New Mexico and HHS discover new PCSK9 vaccine
Read More
Team in France introduces AAC-11-LZ-derived polypeptides
Read More
Achillion presents complement factor D inhibitors
Read More
Shanghai Haiyan Pharmaceutical Technology introduces selective inhibitors of mutant EFGR
Read More
EPIRUS patents Nav1.7 channel blockers
Read More
Responses seen with TargomiRs in mir-16-deficient mesothelioma
Read More
Bioequivalence shown for potential biosimilar PF-06439535 and bevacizumab in healthy volunteers
Read More
Novo Nordisk and MIT to explore next generation of drug delivery devices
Read More
Rockwell Medical launches Triferic for iron deficiency in the U.S.
Read More
Recent acquisition news
Read More
Progression-free survival improved with anlotinib in refractory NSCLC
Read More
Grant supports Treeway's investigation into ALS diagnostic tool
Read More
Janssen-Cilag seeks European approval for daratumumab in multiple myeloma
Read More
Cara Therapeutics starts pivotal phase II/III trial for CR-845 in acute postoperative pain
Read More
GenSpera reports interim results from phase II trial of mipsagargin in glioblastoma
Read More
Trimel Pharmaceuticals changes name to Acerus Pharmaceuticals
Read More
